Astrana Health, INC. (ASTH) — SEC Filings

Q: What are the key financial highlights for Astrana Health, INC.?

Key financial highlights for Astrana Health, INC. are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Astrana Health, INC.?

Key executives at Astrana Health, INC. are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Astrana Health, INC. stock?

Risk factors for Astrana Health, INC. (ASTH) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Astrana Health, INC.?

Forward-looking statements and predictions from Astrana Health, INC. are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Astrana Health, INC.. Recent ARS filing on Apr 17, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.

View Astrana Health, INC. on SEC EDGAR

Overview

Astrana Health, INC. (ASTH) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a ARS filed on Apr 17, 2026: Astrana Health, Inc. filed its Annual Report to Security Holders (ARS) on April 17, 2026, for the period ending December 31, 2025. The filing, with SEC Accession No. 0001104659-26-044545, provides a comprehensive overview of the company's performance and financial standing for the fiscal year 2025.

Sentiment Summary

Across 50 filings, the sentiment breakdown is: 1 bearish, 46 neutral, 3 mixed. The dominant filing sentiment for Astrana Health, INC. is neutral.

Filing Type Overview

Astrana Health, INC. (ASTH) has filed 1 ARS, 1 DEFA14A, 6 10-Q, 36 8-K, 2 8-K/A, 1 DEF 14A, 2 10-K, 1 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (50)

Astrana Health Files 2025 Annual Report — ARS · Apr 17, 2026 Risk: low
Astrana Health, Inc. filed its Annual Report to Security Holders (ARS) on April 17, 2026, for the period ending December 31, 2025. The filing, with SEC Accessio
Astrana Health Files Definitive Proxy Materials — DEFA14A · Apr 17, 2026 Risk: low
Astrana Health, Inc. filed a DEFA14A on April 17, 2026, which contains additional definitive proxy soliciting materials. The filing includes three documents: th
Astrana Health Revenue Soars 63% YOY, But Net Income Plummets — 10-Q · Nov 10, 2025 Risk: high
Astrana Health, Inc. reported a significant increase in total revenue for the nine months ended September 30, 2025, reaching $2,231,243 thousand, up from $1,369
8-K Filing — 8-K · Nov 6, 2025
Astrana Health Files 8-K/A Amendment — 8-K/A · Sep 11, 2025 Risk: low
Astrana Health, Inc. filed an 8-K/A amendment on September 11, 2025, related to an event on July 1, 2025. The filing is a current report pursuant to Section 13
Astrana Health Files 8-K on Financials — 8-K · Aug 7, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on August 7, 2025, reporting on its Results of Operations and Financial Condition, and Financial Statements and Exhibits. The
Astrana Health Revenue Jumps 14% to $1.02B, Net Income Dips — 10-Q · Aug 7, 2025 Risk: medium
Astrana Health, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $1.02 billion, up from $892.5 million in the
Astrana Health Files 8-K on Key Business Events — 8-K · Jul 2, 2025 Risk: medium
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on July 2, 2025, reporting on events as of July 1, 2025. The filing indicates a mater
Astrana Health Files 8-K on Officer Changes & Shareholder Votes — 8-K · Jun 11, 2025 Risk: medium
Astrana Health, Inc. filed an 8-K on June 11, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain o
Astrana Health Files 8-K — 8-K · Jun 4, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on June 4, 2025, reporting information under Regulation FD and including financial statements and exhibits. The company, forme
Astrana Health Files 8-K with Financials — 8-K · May 13, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on May 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Ap
Astrana Health Files Q1 2025 10-Q, Mentions Credit Agreement — 10-Q · May 9, 2025 Risk: medium
Astrana Health, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as Apollo Medical Holdings, Inc., reported on its financia
Astrana Health Files 8-K on Financials — 8-K · May 8, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibits.
Astrana Health Files Definitive Proxy Statement — DEF 14A · Apr 25, 2025 Risk: medium
Astrana Health, Inc. filed its definitive proxy statement on April 25, 2025, for its annual meeting on June 11, 2025. The company, formerly known as Apollo Medi
Astrana Health Appoints New CFO and Directors — 8-K · Mar 28, 2025 Risk: medium
Astrana Health, Inc. announced on March 26, 2025, significant changes in its board and executive team. The company elected two new directors, Dr. David L. Chen
Astrana Health Files 8-K/A Amendment — 8-K/A · Mar 14, 2025 Risk: low
Astrana Health, Inc. filed an 8-K/A on March 14, 2025, to amend a previous filing concerning results of operations and financial condition. The earliest event r
Astrana Health Files 2024 10-K — 10-K · Mar 14, 2025 Risk: medium
Astrana Health, Inc. filed its 2024 10-K on March 14, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Apollo Medical
Astrana Health Files 8-K — 8-K · Mar 10, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on March 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as
Astrana Health Files 8-K — 8-K · Mar 3, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on March 3, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, for
Astrana Health Files 8-K on Material Agreement — 8-K · Feb 27, 2025 Risk: medium
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on February 27, 2025, reporting on events that occurred on February 26, 2025. The fil
Astrana Health Files 8-K for Material Agreement — 8-K · Jan 21, 2025 Risk: medium
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on January 21, 2025, reporting a material definitive agreement entered into on Januar
Astrana Health Files 8-K — 8-K · Jan 14, 2025 Risk: low
Astrana Health, Inc. filed an 8-K on January 14, 2025, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Apollo Me
Astrana Health Confirms Corporate Details and Nasdaq Listing — 8-K · Nov 14, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on November 14, 2024, reporting its principal executive offices are located at 1668 S. Garfield Avenue, 2nd Floor, Alhambra, C
Astrana Health Appoints New CFO, Elects Directors — 8-K · Nov 12, 2024 Risk: medium
Astrana Health, Inc. announced on November 8, 2024, changes in its board and executive team. The company elected two new directors, Dr. David Chen and Mr. David
Astrana Health Files Q3 2024 10-Q — 10-Q · Nov 12, 2024 Risk: medium
Astrana Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qua
Astrana Health Files 8-K for Regulatory Updates — 8-K · Nov 8, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on November 8, 2024, to report on Regulation FD disclosures and financial statements. The filing does not contain specific fin
Astrana Health Files 8-K on Financials — 8-K · Nov 7, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on November 7, 2024, reporting on its results of operations and financial condition, and including financial statements and ex
Astrana Health Files 8-K Under 'Other Events' — 8-K · Oct 7, 2024 Risk: low
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on October 7, 2024, reporting an event that occurred on October 4, 2024. The filing i
Astrana Health Files 8-K — 8-K · Sep 4, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on September 4, 2024, reporting on Regulation FD disclosures and financial statements. The company, formerly known as Apollo M
Astrana Health Files Q2 2024 10-Q — 10-Q · Aug 9, 2024 Risk: medium
Astrana Health, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Apollo Medical Holdings, Inc., reported on its financial
Astrana Health Files 8-K on Financials — 8-K · Aug 7, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, and including financial statements and exhi
Astrana Health Enters Material Definitive Agreement — 8-K · Jul 25, 2024 Risk: medium
On July 24, 2024, Astrana Health, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company, f
Astrana Health Files 8-K — 8-K · Jul 15, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on July 15, 2024, to report other events and financial statements. The company, formerly known as Apollo Medical Holdings, Inc
Astrana Health Files 8-K for Bylaw Amendments — 8-K · Jun 13, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on June 13, 2024, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, forme
Astrana Health Files 8-K on Director Changes and Compensation — 8-K · Jun 12, 2024 Risk: medium
Astrana Health, Inc. filed an 8-K on June 12, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compensator
Astrana Health Enters Material Definitive Agreement — 8-K · May 21, 2024 Risk: medium
On May 20, 2024, Astrana Health, Inc. entered into a Material Definitive Agreement related to a direct financial obligation. The company, formerly known as Apol
Astrana Health Files 8-K for Regulatory Disclosure — 8-K · May 15, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on May 14, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain speci
Astrana Health, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 9, 2024 Risk: medium
Astrana Health, Inc. (ASTH) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Astrana Health, Inc. reported financial results for the quarter ended M
Astrana Health Files 8-K on Financials — 8-K · May 7, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on May 7, 2024, reporting on its Results of Operations and Financial Condition, and filing Financial Statements and Exhibits.
Astrana Health Appoints New Directors and CMO — 8-K · Apr 24, 2024 Risk: medium
Astrana Health, Inc. announced on April 23, 2024, changes in its board of directors and executive team. The company elected two new directors, Dr. David Chen an
Astrana Health Appoints New CMO, Director — 8-K · Apr 5, 2024 Risk: medium
Astrana Health, Inc. announced on April 2, 2024, the appointment of Dr. Steven J. Shikirov as Chief Medical Officer and the election of Ms. Jennifer L. Johnson
Astrana Health Files 8-K — 8-K · Apr 2, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on April 2, 2024, reporting other events and financial statements as of March 29, 2024. The company, formerly known as Apollo
Astrana Health Files 8-K — 8-K · Mar 11, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on March 11, 2024, reporting on financial statements and exhibits. The company, formerly known as Apollo Medical Holdings, Inc
Astrana Health Amends Corporate Charter, Updates Governance — 8-K · Feb 29, 2024 Risk: medium
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on February 28, 2024, reporting amendments to its Articles of Incorporation or Bylaws
Astrana Health, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 29, 2024 Risk:
Astrana Health, Inc. (ASTH) filed a Annual Report (10-K) with the SEC on February 29, 2024. Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed
Astrana Health Files 8-K on Financial Results — 8-K · Feb 27, 2024 Risk: low
Astrana Health, Inc. (formerly Apollo Medical Holdings, Inc.) filed an 8-K on February 27, 2024, to report its "Results of Operations and Financial Condition" a
Astrana Health Files 8-K on Corporate Name Change and Address Update — 8-K · Feb 26, 2024 Risk: low
Astrana Health, Inc. filed an 8-K on February 26, 2024, to report a change in its corporate name from Apollo Medical Holdings, Inc. to Astrana Health, Inc. This
SC 13G/A Filing — SC 13G/A · Feb 13, 2024
Apollo Medical Sells $20M in Stock to Institutional Investor — 8-K · Feb 2, 2024
Apollo Medical Holdings, Inc. (AMEH) announced on January 31, 2024, the issuance of 1,000,000 shares of its common stock at a price of $20.00 per share, totalin
Apollo Medical Amends Bylaws, Requires 2/3 Vote for Director Removal — 8-K · Jan 26, 2024
Apollo Medical Holdings, Inc. filed an 8-K on January 26, 2024, reporting that on January 25, 2024, its Board of Directors approved an amendment to the company'

Risk Profile

Risk Assessment: Of ASTH's 45 recent filings, 1 were flagged as high-risk, 19 as medium-risk, and 25 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Astrana Health, INC.'s most recent 10-Q filing (Nov 10, 2025):

Revenue: $2,231,243
Net Income: $16,488
EPS: $0.33
Debt-to-Equity: N/A
Cash Position: $462,227
Operating Margin: N/A
Total Assets: $2,237,186
Total Debt: $1,002,026

Key Executives

Dr. David L. Chen
Mr. Robert L. W. Smith
Mr. Jianping Wang
Dr. David Chen
Mr. David S. Lee
Ms. Jessica Chen
Mr. Jian Li
Dr. Steven J. Shikirov
Ms. Jennifer L. Johnson
Mr. David J. Smith

Industry Context

The healthcare services industry, particularly managed care and provider networks, is characterized by increasing regulatory scrutiny, evolving payment models (like capitation and value-based care), and significant consolidation. Companies like Astrana Health operate in a competitive landscape where scale, operational efficiency, and effective management of patient populations are critical for profitability.

Top Tags

8-K (14) · financial-reporting (7) · disclosure (6) · financials (6) · corporate-governance (5) · financial-statements (4) · 10-Q (4) · amendment (3) · material-agreement (3) · company-update (3)

Key Numbers

Fiscal Year End: 2025-12-31 — The period covered by the Annual Report to Security Holders.
Total Revenue: $2,231,243 — Increased from $1,369,331 thousand for the nine months ended September 30, 2024, representing a 63% increase.
Net Income Attributable to Astrana Health, Inc.: $16,488 — Decreased from $50,100 thousand for the nine months ended September 30, 2024, representing a 67% decrease.
Capitation, net: $2,061,451 — Increased from $1,239,885 thousand for the nine months ended September 30, 2024, driving revenue growth.
Cost of services: $1,984,756 — Increased from $1,148,422 thousand for the nine months ended September 30, 2024, contributing to reduced net income.
Long-term debt, net of current portion and deferred financing costs: $1,002,026 — Increased from $425,299 thousand as of December 31, 2024, indicating higher leverage.
Total assets: $2,237,186 — Increased from $1,354,894 thousand as of December 31, 2024, reflecting growth and acquisitions.
Interest expense: $32,408 — Increased from $25,028 thousand for the nine months ended September 30, 2024, impacting profitability.
Diluted Earnings Per Share: $0.33 — Decreased from $1.04 for the nine months ended September 30, 2024.
Net Income: $20.3M — Decreased 23.9% for Q2 2025 compared to Q2 2024
Six-Month Total Revenue: $2.01B — Increased from $1.73 billion in 2024
Six-Month Net Income: $39.8M — Decreased from $51.2 million in 2024
General and Administrative Expenses: $105.0M — Increased from $90.2 million in Q2 2024
Revenue Growth Rate: 14.3% — Year-over-year growth for Q2 2025
Net Income Decrease Rate: 23.9% — Year-over-year decrease for Q2 2025

Related Companies

APLS · AMEH

Frequently Asked Questions

What are the latest SEC filings for Astrana Health, INC. (ASTH)?

Astrana Health, INC. has 50 recent SEC filings from Jan 2024 to Apr 2026, including 36 8-K, 6 10-Q, 2 8-K/A. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ASTH filings?

Across 50 filings, the sentiment breakdown is: 1 bearish, 46 neutral, 3 mixed. The dominant sentiment is neutral.

Where can I find Astrana Health, INC. SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Astrana Health, INC. (ASTH) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Astrana Health, INC.?

Key financial highlights from Astrana Health, INC.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for ASTH?

The investment thesis for ASTH includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Astrana Health, INC.?

Key executives identified across Astrana Health, INC.'s filings include Dr. David L. Chen, Mr. Robert L. W. Smith, Mr. Jianping Wang, Dr. David Chen, Mr. David S. Lee and 5 others.

What are the main risk factors for Astrana Health, INC. stock?

Of ASTH's 45 assessed filings, 1 were flagged high-risk, 19 medium-risk, and 25 low-risk.

What are recent predictions and forward guidance from Astrana Health, INC.?

Forward guidance and predictions for Astrana Health, INC. are extracted from SEC filings as they are enriched.